On March 15, 2024, FDA published a white paper titled “Artificial Intelligence & Medical Products: How CBER, CDER, CDRH, and OCP are Working Together” (the AI White Paper) on the use of artificial ...
The US Food and Drug Administration (FDA) has released a discussion paper on emerging and advanced manufacturing technologies concerning the distributed manufacturing (DM) and point-of-care (POC) ...
The US Food and Drug Administration (FDA) has released a discussion paper on using artificial intelligence and machine learning in drug and biological product development. FDA’s discussion paper ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results